![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DNPEP |
Gene summary for DNPEP |
![]() |
Gene information | Species | Human | Gene symbol | DNPEP | Gene ID | 23549 |
Gene name | aspartyl aminopeptidase | |
Gene Alias | ASPEP | |
Cytomap | 2q35 | |
Gene Type | protein-coding | GO ID | GO:0006508 | UniProtAcc | B7Z7F0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23549 | DNPEP | cSCC_p8 | Human | Skin | cSCC | 1.43e-06 | 1.78e-01 | -0.1971 |
23549 | DNPEP | male-WTA | Human | Thyroid | PTC | 1.48e-09 | 1.18e-01 | 0.1037 |
23549 | DNPEP | PTC01 | Human | Thyroid | PTC | 6.97e-05 | 1.70e-01 | 0.1899 |
23549 | DNPEP | PTC04 | Human | Thyroid | PTC | 7.13e-05 | 1.17e-01 | 0.1927 |
23549 | DNPEP | PTC05 | Human | Thyroid | PTC | 6.45e-17 | 3.95e-01 | 0.2065 |
23549 | DNPEP | PTC06 | Human | Thyroid | PTC | 1.69e-18 | 2.98e-01 | 0.2057 |
23549 | DNPEP | PTC07 | Human | Thyroid | PTC | 5.24e-18 | 2.33e-01 | 0.2044 |
23549 | DNPEP | ATC09 | Human | Thyroid | ATC | 2.29e-13 | 4.84e-01 | 0.2871 |
23549 | DNPEP | ATC11 | Human | Thyroid | ATC | 2.01e-10 | 6.28e-01 | 0.3386 |
23549 | DNPEP | ATC12 | Human | Thyroid | ATC | 3.52e-20 | 4.37e-01 | 0.34 |
23549 | DNPEP | ATC13 | Human | Thyroid | ATC | 3.90e-53 | 9.54e-01 | 0.34 |
23549 | DNPEP | ATC1 | Human | Thyroid | ATC | 1.89e-14 | 5.47e-01 | 0.2878 |
23549 | DNPEP | ATC2 | Human | Thyroid | ATC | 4.53e-16 | 1.10e+00 | 0.34 |
23549 | DNPEP | ATC3 | Human | Thyroid | ATC | 1.14e-11 | 5.53e-01 | 0.338 |
23549 | DNPEP | ATC4 | Human | Thyroid | ATC | 6.41e-25 | 5.58e-01 | 0.34 |
23549 | DNPEP | ATC5 | Human | Thyroid | ATC | 1.02e-41 | 1.02e+00 | 0.34 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DNPEP | SNV | Missense_Mutation | novel | c.559N>T | p.Ile187Phe | p.I187F | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A2-A3KC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
DNPEP | SNV | Missense_Mutation | novel | c.214N>A | p.Glu72Lys | p.E72K | protein_coding | tolerated(0.06) | benign(0.056) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
DNPEP | SNV | Missense_Mutation | c.278N>A | p.Ala93Asp | p.A93D | protein_coding | deleterious(0) | probably_damaging(0.966) | TCGA-BH-A0HP-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD | ||
DNPEP | SNV | Missense_Mutation | novel | c.590T>G | p.Phe197Cys | p.F197C | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BH-AB28-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD | |
DNPEP | SNV | Missense_Mutation | c.958G>C | p.Glu320Gln | p.E320Q | protein_coding | deleterious(0.01) | probably_damaging(0.957) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
DNPEP | SNV | Missense_Mutation | novel | c.341A>G | p.Asp114Gly | p.D114G | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
DNPEP | SNV | Missense_Mutation | novel | c.828N>G | p.Ile276Met | p.I276M | protein_coding | deleterious(0) | probably_damaging(0.945) | TCGA-VS-A958-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
DNPEP | SNV | Missense_Mutation | rs781324438 | c.1168G>A | p.Val390Met | p.V390M | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
DNPEP | SNV | Missense_Mutation | c.583G>A | p.Glu195Lys | p.E195K | protein_coding | tolerated(0.15) | possibly_damaging(0.703) | TCGA-AA-3680-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | folinic | PD | ||
DNPEP | SNV | Missense_Mutation | c.1196N>T | p.Tyr399Phe | p.Y399F | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
23549 | DNPEP | ENZYME, NEUTRAL ZINC METALLOPEPTIDASE, DRUGGABLE GENOME, PROTEASE | inhibitor | 252166877 | ||
23549 | DNPEP | ENZYME, NEUTRAL ZINC METALLOPEPTIDASE, DRUGGABLE GENOME, PROTEASE | QGC-001 | |||
23549 | DNPEP | ENZYME, NEUTRAL ZINC METALLOPEPTIDASE, DRUGGABLE GENOME, PROTEASE | inhibitor | CHEMBL2103847 | TOSEDOSTAT |
Page: 1 |